-
1
-
-
0033545541
-
Rising incidence of hepatocellular carcinoma in the United States
-
El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-750.
-
(1999)
N Engl J Med
, vol.340
, pp. 745-750
-
-
El-Serag, H.B.1
Mason, A.C.2
-
2
-
-
63049133092
-
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
-
Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485-1491.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1485-1491
-
-
Altekruse, S.F.1
McGlynn, K.A.2
Reichman, M.E.3
-
3
-
-
84969130321
-
-
AtlantaGAAmerican Cancer Societym, American Cancer Society
-
AtlantaGAAmerican Cancer Society. Cancer Facts & Figures 2012. : American Cancer Society; 2012.
-
(2012)
Cancer Facts & Figures 2012
-
-
-
4
-
-
85006484211
-
-
Centers for Disease Control and Prevention, National Center for Health Statistics, Accessed February 12
-
Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality Files. cdc.gov/Nchs/. Accessed February 12, 2013.
-
(2013)
Mortality Files. cdc.gov/Nchs/
-
-
-
5
-
-
7044272630
-
Hepatocellular carcinoma in cirrhosis: incidence and risk factors
-
Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 suppl 1):S35-S50.
-
(2004)
Gastroenterology
, vol.127
, Issue.5
, pp. S35-S50
-
-
Fattovich, G.1
Stroffolini, T.2
Zagni, I.3
-
6
-
-
84860287080
-
Epidemiology of viral hepatitis and hepatocellular carcinoma
-
El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264-1273.e1.
-
(2012)
Gastroenterology
, vol.142
, pp. 1264-1273
-
-
El-Serag, H.B.1
-
7
-
-
79952231921
-
Management of hepatocellular carcinoma: an update
-
Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
8
-
-
84858658381
-
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
-
European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943.
-
(2012)
J Hepatol
, vol.56
, pp. 908-943
-
-
-
9
-
-
84984586846
-
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
-
Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474.
-
(2010)
Hepatol Int
, vol.4
, pp. 439-474
-
-
Omata, M.1
Lesmana, L.A.2
Tateishi, R.3
-
11
-
-
85006486235
-
-
Fort Washington, PA, National Comprehensive Cancer Network
-
National Comprehensive Cancer Network. NCCN Guidelines Version 2.2012: Hepatocellular Carcinoma. Fort Washington, PA: National Comprehensive Cancer Network; 2012.
-
(2012)
NCCN Guidelines Version 2.2012: Hepatocellular Carcinoma
-
-
-
12
-
-
79551648518
-
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States
-
Davila JA, Henderson L, Kramer JR, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011;154:85-93.
-
(2011)
Ann Intern Med
, vol.154
, pp. 85-93
-
-
Davila, J.A.1
Henderson, L.2
Kramer, J.R.3
-
13
-
-
70450240875
-
Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting
-
Wong CR, Garcia RT, Trinh HN, et al. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci. 2009;54:2712-2721.
-
(2009)
Dig Dis Sci
, vol.54
, pp. 2712-2721
-
-
Wong, C.R.1
Garcia, R.T.2
Trinh, H.N.3
-
14
-
-
33645683837
-
Analytical methods and database design: implications for transplant researchers, 2005
-
Levine GN, McCullough KP, Rodgers AM, et al. Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant. 2006;6(5 pt 2):1228-1242.
-
(2006)
Am J Transplant
, vol.6
, Issue.5
, pp. 1228-1242
-
-
Levine, G.N.1
McCullough, K.P.2
Rodgers, A.M.3
-
15
-
-
0033019013
-
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease
-
Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664-669.
-
(1999)
Hepatology
, vol.29
, pp. 664-669
-
-
Caldwell, S.H.1
Oelsner, D.H.2
Iezzoni, J.C.3
-
16
-
-
0033797838
-
Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study
-
Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology. 2000;32(4 pt 1):689-692.
-
(2000)
Hepatology.
, vol.32
, Issue.4
, pp. 689-692
-
-
Poonawala, A.1
Nair, S.P.2
Thuluvath, P.J.3
-
17
-
-
0015854966
-
Transection of the oesophagus for bleeding oesophageal varices
-
Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649.
-
(1973)
Br J Surg
, vol.60
, pp. 646-649
-
-
Pugh, R.N.1
Murray-Lyon, I.M.2
Dawson, J.L.3
-
18
-
-
0034728356
-
What do we mean by validating a prognostic model?
-
Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19:453-473.
-
(2000)
Stat Med
, vol.19
, pp. 453-473
-
-
Altman, D.G.1
Royston, P.2
-
19
-
-
0030069896
-
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
-
Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
-
(1996)
Stat Med
, vol.15
, pp. 361-387
-
-
Harrell, F.E.1
Lee, K.L.2
Mark, D.B.3
-
20
-
-
57349116772
-
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon
-
Di Bisceglie AM, Shiffman ML, Everson GT, et al. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008;359:2429-2441.
-
(2008)
N Engl J Med
, vol.359
, pp. 2429-2441
-
-
Di Bisceglie, A.M.1
Shiffman, M.L.2
Everson, G.T.3
-
21
-
-
79952316752
-
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C
-
quiz e12
-
Lok AS, Everhart JE, Wright EC, et al; HALT-C Trial Group. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology. 2011;140:840-849; quiz e12.
-
(2011)
Gastroenterology
, vol.140
, pp. 840-849
-
-
Lok, A.S.1
Everhart, J.E.2
Wright, E.C.3
-
22
-
-
0033936550
-
Time-dependant ROC curves for censored survival data and a diagnostic marker
-
Heagerty PJ, Lumley T, Pepe MS. Time-dependant ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000;56:337-344.
-
(2000)
Biometrics
, vol.56
, pp. 337-344
-
-
Heagerty, P.J.1
Lumley, T.2
Pepe, M.S.3
-
23
-
-
56949094767
-
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
-
Yuen MF, Tanaka Y, Fong DY, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50:80-88.
-
(2009)
J Hepatol
, vol.50
, pp. 80-88
-
-
Yuen, M.F.1
Tanaka, Y.2
Fong, D.Y.3
-
24
-
-
59849093175
-
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
-
Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138-148.
-
(2009)
Gastroenterology
, vol.136
, pp. 138-148
-
-
Lok, A.S.1
Seeff, L.B.2
Morgan, T.R.3
-
25
-
-
84984550778
-
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
-
Yang HI, Yuen MF, Chan HL, et al. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol. 2011;12:568-574.
-
(2011)
Lancet Oncol
, vol.12
, pp. 568-574
-
-
Yang, H.I.1
Yuen, M.F.2
Chan, H.L.3
-
26
-
-
84863774717
-
Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: The Japan Public Health Center-based Prospective Study Cohort II
-
Michikawa T, Inoue M, Sawada N, et al; Japan Public Health Center-based Prospective Study Group. Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: The Japan Public Health Center-based Prospective Study Cohort II. Prev Med. 2012;55:137-143.
-
(2012)
Prev Med
, vol.55
, pp. 137-143
-
-
Michikawa, T.1
Inoue, M.2
Sawada, N.3
-
27
-
-
0037369657
-
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
-
Velazquez RF, Rodriguez M, Navascues CA, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003;37:520-527.
-
(2003)
Hepatology
, vol.37
, pp. 520-527
-
-
Velazquez, R.F.1
Rodriguez, M.2
Navascues, C.A.3
-
28
-
-
84855306790
-
Highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein: a new tool for the management of hepatocellular carcinoma
-
Toyoda H, Kumada T, Tada T. Highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein: a new tool for the management of hepatocellular carcinoma. Oncology. 2011;81(suppl 1):61-65.
-
(2011)
Oncology
, vol.81
, pp. 61-65
-
-
Toyoda, H.1
Kumada, T.2
Tada, T.3
|